lung cancer
Conditions
Interventions
A:PCIA+ Flurbiprofen Axetil Injection + buprenorphine transdermal patch
B:PCIA+ Flurbiprofen Axetil Injection
C:Flurbiprofen Axetil Injection + buprenorphine transdermal patch
Sponsors
Affiliated Hospital of Qingdao University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) voluntarily participate in the study and sign informed consent by myself or his legal representative (if necessary); 2) Aged 18-75 years male and female; 3) operation mode lobectomy (single leaf or lobar) excision + systematic lymphadenectomy; 4) preoperative staging was excluded from late stage and distant metastasis; 5) to understand the use of visual analogue pain score (VAS) and intravenous patient controlled analgesia (PCIA); 6) non pregnancy patients.
Exclusion criteria
Exclusion criteria: 1) anticancer therapy such as radiotherapy and chemotherapy before operation; 2) the mode of operation was cuneiform resection / pneumonectomy. 3) patients with serious cardiovascular or cerebrovascular diseases or incomplete medical records. 4) patients who did not sign the informed consent form; 5) preoperative application of pain medication or serious postoperative complications; 6) patients with postoperative bleeding or persistent pulmonary leakage need re-operation; 7) patients who are participating in other clinical trials; 8) the researchers believe that other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The best solution for postoperative analgesia in Department of thoracic surgery; | — |
Countries
China
Contacts
Public ContactYongjie Wang
Affiliated Hospital of Qiingdao University
Outcome results
None listed